Passage Bio's total assets for Q4 2025 were $62.28M, a decrease of -16.02% from the previous quarter. PASG total liabilities were $43.53M for the fiscal quarter, a 1.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.